Tetra Bio-Pharma Inc. Receives Notice of Authorization from Health Canada for the Conduct of its Clinical Trial with its PPTGR topical product

OTTAWA, ONTARIO -- (Marketwired) -- 02/01/17 -- PhytoPain Pharma Inc. ("PPP"), a subsidiary of Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (CSE: TBP), a pharmaceutical company focused on developing and commercializing therapeutic cannabis-based products for the t ...